Aurobindo Pharma Limited (NSE:AUROPHARMA)
India · Delayed Price · Currency is INR 1,105.00
-4.00 (-0.36%)
Oct 16, 2025, 3:30 PM IST
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 644.11 billion as of October 16, 2025. Its market cap has decreased by -26.81% in one year.
Market Cap
644.11B
Enterprise Value
644.32B
Revenue
320.25B
Ranking
n/a
PE Ratio
19.02
Stock Price
1,105.00
Market Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 644.11B, an increase of 6,607.18%. That is a compound annual growth rate of 19.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 644.11B | -16.90% |
| Dec 31, 2024 | 775.08B | 22.03% |
| Dec 29, 2023 | 635.16B | 147.32% |
| Dec 30, 2022 | 256.82B | -40.31% |
| Dec 31, 2021 | 430.28B | -20.29% |
| Dec 31, 2020 | 539.83B | 101.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,003.05B |
| Divi's Laboratories | 1,740.41B |
| Cipla | 1,261.57B |
| Apollo Hospitals Enterprise | 1,102.97B |
| Mankind Pharma | 1,008.16B |
| Zydus Lifesciences | 1,001.71B |
| Fortis Healthcare | 826.79B |
| Alkem Laboratories | 656.71B |